Skip to main content
Fig. 1 | Chinese Medicine

Fig. 1

From: Wangbi granule as a combination therapy to achieve clinical deep remission in rheumatoid arthritis: protocol for a multicenter, triple-blind, randomised, placebo-controlled trial

Fig. 1

The flow diagram of the trial. T0, 0–1 day treatment (baseline); T1, 4 week treatment; T2, 8 week treatment; T3, 12 week treatment; T4, 1 month after end of treatment; DAS28 disease activity score derivative for 28 joints, ACR50 American College of Rheumatology 50% response criteria, VAS visual analogue scale for pain, FS-14 fatigue scale-14, HAQ-DI health assessment questionnaire disability index, ALT alanine aminotransferase, AST aspartate aminotransferase, Scr serum creatinine, ESR erythrocyte sedimentation rate, CRP C-reactive protein, RF rheumatoid factors, ACPA anti-citrullinated protein antibodies

Back to article page

Chinese Medicine

ISSN: 1749-8546

Contact us